Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MATTEL INC /DE/ | 270,666 | reported | 01 Aug 2017 | tx 254+3,427,068−2,521,489 |
| Niagen Bioscience, Inc. | 89,189 | reported | 12 Aug 2022 | tx 14+1,589,011 |
| Polaris Inc. | 22,075.65 | reported | 01 May 2025 | tx 59+33,630.22−15,008.96 |
| BECKMAN COULTER INC | 0 | reported | 30 Jun 2011 | tx 92+38,505.03−45,759.31 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 May 2025 | GRANT_AWARD | Polaris Inc. | 4,320 | 34.72 USD | |
| 25 Apr 2024 | GRANT_AWARD | Polaris Inc. | 1,801 | 83.28 USD | |
| 02 Oct 2023 | GRANT_AWARD | Polaris Inc. | 359.27 | 102.64 USD | |
| 03 Aug 2023 | SALE | Polaris Inc. | 3,225 | 133.28 USD | |
| 27 Jul 2023 | SALE | Polaris Inc. | 1,615 | 134.33 USD | |
| 03 Jul 2023 | GRANT_AWARD | Polaris Inc. | 301.69 | 122.23 USD | |
| 27 Apr 2023 | GRANT_AWARD | Polaris Inc. | 1,380 | 108.71 USD | |
| 03 Apr 2023 | GRANT_AWARD | Polaris Inc. | 309.13 | 111.20 USD | |
| 03 Jan 2023 | GRANT_AWARD | Polaris Inc. | 342.04 | 100.50 USD | |
| 03 Oct 2022 | GRANT_AWARD | Polaris Inc. | 175.39 | 98.00 USD | |
| 12 Aug 2022 | GRANT_AWARD | Niagen Bioscience, Inc. | 89,189 | 0.00 USD | deriv |
| 01 Jul 2022 | GRANT_AWARD | Polaris Inc. | 170.13 | 101.03 USD | |
| 28 Apr 2022 | GRANT_AWARD | Polaris Inc. | 1,486 | 97.63 USD | |
| 01 Apr 2022 | GRANT_AWARD | Polaris Inc. | 149.73 | 106.44 USD | |
| 17 Feb 2022 | GRANT_AWARD | Niagen Bioscience, Inc. | 122,374 | 0.00 USD | deriv |
| 03 Jan 2022 | GRANT_AWARD | Polaris Inc. | 144.45 | 110.33 USD | |
| 28 Oct 2021 | SALE | Polaris Inc. | 10,168.96 | 115.27 USD | |
| 01 Oct 2021 | GRANT_AWARD | Polaris Inc. | 273.64 | 121.25 USD | |
| 01 Jul 2021 | GRANT_AWARD | Polaris Inc. | 227.98 | 134.33 USD | |
| 29 Apr 2021 | GRANT_AWARD | Polaris Inc. | 1,018 | 137.52 USD | |
| 01 Apr 2021 | GRANT_AWARD | Polaris Inc. | 217.71 | 134.93 USD | |
| 15 Mar 2021 | GRANT_AWARD | Niagen Bioscience, Inc. | 28,461 | 0.00 USD | deriv |
| 04 Jan 2021 | GRANT_AWARD | Polaris Inc. | 306.92 | 95.71 USD | |
| 06 Nov 2020 | PURCHASE | Niagen Bioscience, Inc. | 5,000 | 4.43 USD | first after silence |
| 01 Oct 2020 | GRANT_AWARD | Polaris Inc. | 310.72 | 94.54 USD |
3 purchases reported after at least 12 months of silence — most recent on 06 Nov 2020.